ArticleImmunoTargets and therapy2025

Recombinant Antithrombin Alleviated Pulmonary Injury and Inflammation in LPS-Induced ARDS by Inhibiting IL17a/NF-κB Signaling.

Chen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.